vs
Digimarc CORP（DMRC）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是Digimarc CORP的1.0倍（$9.1M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -60.3%，领先13.1%），Digimarc CORP同比增速更快（2.9% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $895.0K），过去两年Digimarc CORP的营收复合增速更高（-5.3% vs -6.7%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
DMRC vs PLX — 直观对比
营收规模更大
PLX
是对方的1.0倍
$8.9M
营收增速更快
DMRC
高出52.8%
-49.9%
净利率更高
DMRC
高出13.1%
-60.3%
自由现金流更多
PLX
多$732.0K
$895.0K
两年增速更快
DMRC
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $9.1M |
| 净利润 | $-4.2M | $-5.5M |
| 毛利率 | 63.5% | 49.4% |
| 营业利润率 | -48.2% | -51.1% |
| 净利率 | -47.2% | -60.3% |
| 营收同比 | 2.9% | -49.9% |
| 净利润同比 | 51.4% | -184.8% |
| 每股收益（稀释后） | $-0.18 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCPLX
| Q4 25 | $8.9M | $9.1M | ||
| Q3 25 | $7.6M | $17.9M | ||
| Q2 25 | $8.0M | $15.7M | ||
| Q1 25 | $9.4M | $10.1M | ||
| Q4 24 | $8.7M | $18.2M | ||
| Q3 24 | $9.4M | $18.0M | ||
| Q2 24 | $10.4M | $13.5M | ||
| Q1 24 | $9.9M | — |
净利润DMRCPLX
| Q4 25 | $-4.2M | $-5.5M | ||
| Q3 25 | $-8.2M | $2.4M | ||
| Q2 25 | $-8.2M | $164.0K | ||
| Q1 25 | $-11.7M | $-3.6M | ||
| Q4 24 | $-8.6M | $6.5M | ||
| Q3 24 | $-10.8M | $3.2M | ||
| Q2 24 | $-9.3M | $-2.2M | ||
| Q1 24 | $-10.3M | — |
毛利率DMRCPLX
| Q4 25 | 63.5% | 49.4% | ||
| Q3 25 | 58.3% | 53.4% | ||
| Q2 25 | 58.8% | 62.5% | ||
| Q1 25 | 65.0% | 19.1% | ||
| Q4 24 | 60.8% | 78.7% | ||
| Q3 24 | 62.4% | 53.4% | ||
| Q2 24 | 66.1% | 29.8% | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCPLX
| Q4 25 | -48.2% | -51.1% | ||
| Q3 25 | -109.7% | 11.9% | ||
| Q2 25 | -105.2% | 7.5% | ||
| Q1 25 | -128.9% | -41.0% | ||
| Q4 24 | -105.1% | 39.6% | ||
| Q3 24 | -120.4% | 22.2% | ||
| Q2 24 | -96.2% | -18.0% | ||
| Q1 24 | -109.2% | — |
净利率DMRCPLX
| Q4 25 | -47.2% | -60.3% | ||
| Q3 25 | -106.9% | 13.2% | ||
| Q2 25 | -102.6% | 1.0% | ||
| Q1 25 | -125.2% | -35.8% | ||
| Q4 24 | -99.9% | 35.6% | ||
| Q3 24 | -113.9% | 18.0% | ||
| Q2 24 | -89.3% | -16.4% | ||
| Q1 24 | -104.0% | — |
每股收益（稀释后）DMRCPLX
| Q4 25 | $-0.18 | $-0.06 | ||
| Q3 25 | $-0.38 | $0.03 | ||
| Q2 25 | $-0.38 | $0.00 | ||
| Q1 25 | $-0.55 | $-0.05 | ||
| Q4 24 | $-0.40 | $0.10 | ||
| Q3 24 | $-0.50 | $0.03 | ||
| Q2 24 | $-0.43 | $-0.03 | ||
| Q1 24 | $-0.50 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $48.2M |
| 总资产 | $53.0M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCPLX
| Q4 25 | $12.9M | $14.7M | ||
| Q3 25 | $12.6M | $13.6M | ||
| Q2 25 | $16.1M | $17.9M | ||
| Q1 25 | $21.6M | $19.5M | ||
| Q4 24 | $28.7M | $19.8M | ||
| Q3 24 | $33.7M | $27.4M | ||
| Q2 24 | $41.5M | $23.4M | ||
| Q1 24 | $48.9M | — |
股东权益DMRCPLX
| Q4 25 | $40.2M | $48.2M | ||
| Q3 25 | $41.4M | $52.9M | ||
| Q2 25 | $46.5M | $49.9M | ||
| Q1 25 | $50.0M | $45.2M | ||
| Q4 24 | $61.4M | $43.2M | ||
| Q3 24 | $70.2M | $32.4M | ||
| Q2 24 | $77.2M | $28.6M | ||
| Q1 24 | $84.5M | — |
总资产DMRCPLX
| Q4 25 | $53.0M | $82.3M | ||
| Q3 25 | $55.4M | $82.3M | ||
| Q2 25 | $60.7M | $78.5M | ||
| Q1 25 | $66.5M | $73.9M | ||
| Q4 24 | $75.8M | $73.4M | ||
| Q3 24 | $85.0M | $61.6M | ||
| Q2 24 | $93.4M | $91.5M | ||
| Q1 24 | $99.7M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $1.6M |
| 自由现金流率自由现金流/营收 | 10.0% | 17.8% |
| 资本支出强度资本支出/营收 | 1.1% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流DMRCPLX
| Q4 25 | $991.0K | $2.0M | ||
| Q3 25 | $-2.6M | $-3.7M | ||
| Q2 25 | $-4.7M | $-5.2M | ||
| Q1 25 | $-5.5M | $-5.1M | ||
| Q4 24 | $-4.2M | $4.0M | ||
| Q3 24 | $-7.1M | $4.1M | ||
| Q2 24 | $-6.8M | $-3.6M | ||
| Q1 24 | $-8.4M | — |
自由现金流DMRCPLX
| Q4 25 | $895.0K | $1.6M | ||
| Q3 25 | $-2.8M | $-4.2M | ||
| Q2 25 | $-4.9M | $-5.7M | ||
| Q1 25 | $-5.5M | $-5.4M | ||
| Q4 24 | $-4.2M | $3.6M | ||
| Q3 24 | $-7.2M | $4.0M | ||
| Q2 24 | $-6.9M | $-3.8M | ||
| Q1 24 | $-8.5M | — |
自由现金流率DMRCPLX
| Q4 25 | 10.0% | 17.8% | ||
| Q3 25 | -36.9% | -23.7% | ||
| Q2 25 | -61.0% | -36.2% | ||
| Q1 25 | -59.1% | -53.0% | ||
| Q4 24 | -49.1% | 19.6% | ||
| Q3 24 | -75.7% | 22.4% | ||
| Q2 24 | -66.1% | -28.1% | ||
| Q1 24 | -85.8% | — |
资本支出强度DMRCPLX
| Q4 25 | 1.1% | 4.4% | ||
| Q3 25 | 2.9% | 2.8% | ||
| Q2 25 | 2.5% | 2.8% | ||
| Q1 25 | 0.6% | 3.0% | ||
| Q4 24 | 0.2% | 2.3% | ||
| Q3 24 | 0.7% | 0.5% | ||
| Q2 24 | 0.3% | 1.3% | ||
| Q1 24 | 1.1% | — |
现金转化率DMRCPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
